Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
15M
-
Shares change
-
+86.8K
-
Total reported value, excl. options
-
$181M
-
Value change
-
-$2.35M
-
Number of buys
-
29
-
Number of sells
-
-23
-
Price
-
$12.08
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q1 2020
61 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q1 2020.
TransMedics Group, Inc. - Common Stock (TMDX) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15M shares
of 33.9M outstanding shares and own 44.19% of the company stock.
Largest 10 shareholders include ABRAMS CAPITAL MANAGEMENT, L.P. (3.5M shares), FMR LLC (3.18M shares), CREDIT SUISSE AG/ (1.2M shares), BlackRock Inc. (1.08M shares), Sandhill Capital Partners LLC (771K shares), VANGUARD GROUP INC (672K shares), RTW INVESTMENTS, LP (503K shares), FEDERATED HERMES, INC. (488K shares), Zimmer Partners, LP (471K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (459K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.